Cortegiani, Andrea http://orcid.org/0000-0003-1416-9993
Misseri, Giovanni
Giarratano, Antonino
Bassetti, Matteo
Eyre, David
Article History
Received: 29 March 2019
Accepted: 17 April 2019
First Online: 2 May 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: AC is a member of the Advisory Board of Critical Care. GM and DE declare to have no competing interests. AG received grants, fees for educational presentation, and advisory board membership, without any relationship to the submitted work, from Pfizer, Merck Sharp, and Gilead. Outside the submitted work, MB has received funding for scientific advisory boards, travel and speaker honoraria from Angelini, AstraZeneca, Bayer, Biomerieux, Cidara, Cubist, Gilead, Pfizer, Melinta Therapeutics, Menarini, MSD, Nabriva, Paratek, Roche, Shionogi, Tetraphase, The Medicines Company and Astellas Pharma Inc.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.